A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11β-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 7, 2005, Pages 4157-4162

  San Millán, José L ^a   Botella Carretero, José I ^a   Álvarez Blasco, Francisco ^a   Luque Ramírez, Manuel ^a   Sancho, José ^a   Moghetti, Paolo ^b   Escobar Morreale, Héctor F ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 3ALPHA(OR 20BETA) HYDROXYSTEROID DEHYDROGENASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; OXIDOREDUCTASE;

ADULT; ALLELE; ARTICLE; CELL MUTANT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; GENE; GENE FUNCTION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; R453Q GENE; UNIVERSITY HOSPITAL;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADULT; CARBOHYDRATE DEHYDROGENASES; CASE-CONTROL STUDIES; CORTISONE REDUCTASE; FEMALE; GENOTYPE; HUMANS; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, GENETIC;

EID: 23044516980     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1523     Document Type: Article

References (19)

1. Draper N, Walker EA, Bujalska IJ, Tomlinson JW, Chalder SM, Arlt W, Lavery GG, Bedendo O, Ray DW, Laing I, Malunowicz E, White PC, Hewison M, Mason PJ, Connell JM, Shackleton CH, Stewart PM 2003 Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet 34:434-439
2. Stewart PM 2003 Tissue-specific Cushing's syndrome, 11β- hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action. Eur J Endocrinol 149:163-168
3. Rodin A, Thakkar H, Taylor N, Clayton R 1994 Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11β-hydroxysteroid dehydrogenase. N Engl J Med 330:460-465
4. Azziz R, Dewailly D, Owerbach D 1994 Nonclassic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 78:810-815
5. Zawadzki JK, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications; 377-384
6. National Institutes of Health 1998 Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 6(Suppl 2):51S-209S
7. San Millan JL, Corton M, Villuendas G, Sancho J, Peral B, Escobar-Morreale HF 2004 Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. J Clin Endocrinol Metab 89:2640-2646
8. Escobar-Morreale HF, Serrano-Gotarredona J, Varela C, García-Robles R, Sancho JM 1997 Circulating leptin concentrations in women with hirsutism. Fertil Steril 68:898-906
9. Escobar-Morreale HF, Lasuncion MA, Sancho J 2000 Treatment of hirsutism with ethinyl estradiol-desogestrel contraceptive pills has beneficial effects on the lipid profile and improves insulin sensitivity. Fertil Steril 74:816-819
10. Vermeulen A, Verdonck L, Kaufman JM 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma insulin and glucose concentrations in man. Diabetologia 28:412-419
12. Schmidt NA, Borburgh HJ, Penders TJ, WeykampCW1985 Steroid profiling: an update. Clin Chem 31:637-639
13. Draper N, Powell BL, Franks S, Stewart PM, McCarthy MI, Prevalence of cortisone reductase deficiency mutations in 373 cases of PCOS. Program of the 86th Annual Meeting of The Endocrine Society, New Orleans, LA, 2004 (Abstract P1-234)
14. Buchner A, Faul F, Erdfelder E 1997 G*Power: a priori, post-hoc, and compromise power analyses for the Macintosh (software), 2.1.2 ed. Trier, Germany: University of Trier
15. Cohen J 1988 Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum
16. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM 2004 11β-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev 25:831-866
17. Azziz R, Bradley EL, Potter HD, Boots LR 1995 Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation. J Clin Endocrinol Metab 80:400-405
18. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR 2004 Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 89:453-462
19. Escobar-Morreale HF, Luque-Ramirez M, San Millan JL 2005 The moleculargenetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev 26:251-282